Divergent and Convergent Mechanisms of the Integrative Activity of Mammalian Brain

Zhurnal Vysshei Nervnoi Deyatelnosti Imeni I.P. Pavlova

Volumn 51, Issue 4, 2001, Pages 525-528

  Bazyan, A S ^a  

^a INSTITUTE OF HIGHER NERVOUS ACTIVITY AND NEUROPHYSIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; GLUTAMIC ACID; NEUROTRANSMITTER RECEPTOR;

ANIMAL; BRAIN; EMOTION; METABOLISM; MOTIVATION; PHYSIOLOGY; REVIEW; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN; EMOTIONS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MOTIVATION; NEUROTRANSMITTER AGENTS; RECEPTORS, NEUROTRANSMITTER; SYNAPTIC TRANSMISSION;

EID: 0035405132     PISSN: 00444677     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Antkiewicz-Michaluk L. Receptor and voltage-operated ion channels in the central nervous system // Pol. J. Pharmacol. 1995. V. 47. No. 3. P. 253.
2. Bazyan A.S., Berkinblit M.B., Kruglikov R.I. Regulation of noradrenaline secretion by autoadrenoreceptors. I. The stabilization of a quantity of secreted transmitter by autoreceptors, in the series of successive depolarization // Biogenic Amines. 1988. V. 5. No 2. P. 125.
3. Bazyan A.S., Berkinblit M.B., Kruglikov R.I. Regulation of noradrenaline secretion by autoadrenoreceptors. II. The corelation between intensity of noradrenaline secretion and the displacement in the direction of higher noradrenaline concentration of stable secretion zone formed by α- and β-autoreceptors // Biogenic Amines. 1988. V. 5. No 2. P. 137.
4. Bazyan A.S. Principles of functioning and physiological role of autoadrenoreceptors of mammalian nervous system // Biogenic Amines. 1992. V. 9. No 3. P. 225.
5. Bazyan A.S., Getsova V.N., Orlova N.V. Duration of the persistence of movement activity in rats induced by single injections of haloperidol // Neuroscience and Behav. Physiol. 1998. V. 28. No 2. P. 136.
6. Bazyan A.S., Getsova V.N., Orlova N.V. Haloperidol catalepsy consolidstion in the rat as a model of neuromodulatory integration // Neurosci. 2000. V. 99. No 2. P. 279.
7. Cohen B.H., Herschel M., Miller E., Maybery H. Radioreceptor assay of haloperidol tissue levels in the rat // Neuropharmacology. 1980. V. 19. No 5. P. 663.
8. Corda M. G., Orlandi M., Lecca D., Giorgi O. Decrease in GABA-ergic function induced by pentylenetetrazole kindling in rats: antagonism by MK-801 // J. Pharmacol. and Exptl Therap. 1992. V. 262. No 2. P. 792.
9. Costa A.M., Spence K.T., Smith S.S., Ffrench-Mullen J.M. Withdrawal from the endogenous steroid progesterone results in GABA(A) currents insensitive to benzodiazepine modulation in rat CA1 hippocampus // J. Neurophysiol. 1995. V. 74. No 1. P. 464.
10. Depaulis A., Helfer V., Deransart C., Marescaux C. Anxiogenic-like consequences in animal models of complex partial seizures. // Neurosci. Biobehav. Rev. 1997. V. 21. No 6. P. 767.
11. Donevan S.D., Rogawski MA. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines // Neuroscience. 1998. V. 87. No 3. P. 615.
12. Durmuller N., Craggs M., Meldrum B.S. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures // Epilepsy Res. 1994. V. 17. No 2. P. 167.
13. Evans M.S., Viola-McCabe K.E. Midazolam inhibits long-term potentiation through modulation of GABA(A) receptors // Neuropharmacology. 1996. V. 35. No 3. P. 347.
14. File S.E., Mabbutt P.S., Becker A., et al. Short-term rebound anxiolytic effects and long-term changes in platelet benzodiazepine binding after pentylenetetrazole-kindling in two strains of rat // Anxiety. 1996. V. 2. No 3. P. 109.
15. Friedman L.K., Gibbs T.T., Farb D.H. Gamma-aminobutyric acid A receptor regulation: heterologous uncoupling of modulatory site interactions induced by chronic steroid, barbiturate, benzodiazepine, or GABA treatment in culture // Brain Res. 1996. V. 707. No 1. P. 100.
16. Higashima M., Kinoshita H., Koshino Y. Differences in the effects of zolpidem and diazepam on recurrent inhi-bition and long-term potentiation in rat hippocampal slices. // Neurosci. Lett. 1998. V. 245. No 2. P. 77.
17. Ito K., Asakura A., Yamada Y., et al. Prediction of the therapeutic dose for benzodiazepine anxiolytics based on receptor occupancy theory // Biopharmacol. Drug. Dispos. 1997. V 18. No 4. P. 293.
18. Iversen L.L. Function and distribution of peptides in the nervous system // Biochem. Soc. Trans. 1985. V. 13. No 1. P. 35.
19. Iversen L.L. MK-801 (dizocilpine maleate) - NMDA receptor antagonist // Neurotransmissions. 1994. V. 10. No 1. P. 1.
20. Jaskiw G.E., Hussain G., Meltzer H.Y. Frontal cortex lesions modify the cataleptogenic properties of haloperidol but not of clozapine. // Biol. Psychiatry. 1993. V. 34. No 3. P. 188.
21. Johnston J.D., Price S.A., Bristow D.R. Flunitrazepam rapidly reduces GABA(A) receptor subunit protein expression via a protein kinase C-dependent mechanism // Brit. J. Pharmacol. 1998. V. 124. No 7. P. 1338.
22. Koff J.M., Pritchard G.A., Greenblatt D.J., Miller L.G. The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation // Pharmacology. 1997. V. 55. No 5. P. 217.
23. Kokaia M., Pratt G.D., Elmer E., et al. Biphasic differential changes of GABA(A) receptor subunit mRNA levels in dentate gyrus granule cells following recurrent kindling-induced seizures // Mol. Brain Res. 1994. V. 23. No 4. P. 323.
24. Kuznetsova G.D., Midzianovskaia I.S. Direct current potential shifts during spike-wave discharge in animal model of absence epilepsy // Focus of Epilepsy. Intern. Conf. Quebec, Canada, May, 1999. P. 53.
25. Lewin E., Bleck V., Dildy-Mayfield J.E., Harris R.A. GABA(A) and glutamate receptor subunit mRNAs in cortex of mice chemically kindled with FG 7142 // Mol. Brain Res. 1994. V. 22. No 1-4. P. 320.
26. Li H., Rogawski M.A. GluR5 kainate receptor mediated synaptic transmission in rat basolateral amygdala in vitro // Neuropharmacology. 1998. V. 37. No 10-11. P. 1279.
27. Lipska B.K., Jaskiw G.E., Braun A.R., Weinberger D.R. Prefrontal cortical and hippocampal modulation of halo-peridol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat // Biol. Psychiatry. 1995. V. 38. No 4. P. 255.
28. Mayford M., Abel T., Kandel E.R. Transgenic approaches to cognition // Current. Opin. Neurobiol. 1995. V. 5. No 1. p. 141.
29. Mednikova Y.S., Karnup S.V., Loseva E.V. Cholinergic excitation of dendrites in neocortical neurons // Neuroscience. 1998. V. 87. No 4. P. 783.
30. Moran M.H., Smith S.S. Progesterone withdrawal I: proconvulsant effects // Brain Res. 1998. V. 807. No 1-2. P. 84.
31. Nicoll R.A., Malenka R.C., Kauer J.A. Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system // Physiol. Rev. 1990. V. 70. No 2. P. 513.
32. Niles L.P., Smith L.J., Tenn C.C. Modulation of c-fos expression in the rat striatum by diazepam. // Neurosci. Lett. 1997. V. 236. No 1. P. 5.
33. Olsen R.W., Yang J., King R.G. et al. Barbiturate and benzodiazepine modulation of GABA receptor binding and function // Life Sci. 1986. V. 39. No 21. P. 1969.
34. Pratt, G.D., Kokaia M., Bengzon, J. et al. Differential regulation of N-methyl-D-aspartate receptor subunit messenger RNAs in kindling-induced epileptogenesis // Neuroscience. 1993. V. 57. No 2. P. 307.
35. Ready D.S., Kulkarni S.K. Reversal of benzodiazepine inverse agonist FG 7142-induced anxiety syndrome by neurosteroids in mice // Methods Find. Exptl Clin. Pharmacol. 1997. V. 19. No 10. P. 665.
36. Rodgers R.J., Cao B.J., Dalvi A., Holmes A. Animal models of anxiety: an ethological perspective // Braz. J. Med. Biol. Res. 1997. V. 30. No 3. P. 289.
37. Rosenberg H.C. Differential expression of benzodiazepine anticonvulsant cross-tolerance according to time following flurazepam or diazepam treatment // Pharmacol. Biochem. and Behav. 1995. V. 51. No 2-3. P. 363.
38. Rundfeldt C., Wlaz P., Honack D., Loscher W. Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecamil // J. Pharmacol. and Exptl. Therap. 1995. V. 275. No 2. P. 693.
39. Sanberg P.R. Neuroleptic-induced emotional defecation: effects of pimozide and apomorphine // Physiol. and Behav. 1989. V. 46. No 2. P. 199.
40. Seabrook G.R., Easter A., Dawson G.R., Bowery B.J. Modulation of long-term potentiation in CA1 region of mouse hippocampal brain slices by GABA(A) receptor benzodiazepine site ligands // Neuropharmacology. 1997. V. 36. No 6. P. 823.
41. Sousa A., Ticku M.K. Interactions of the neurosteroid dehydroepiandrosterone sulfate with the GABA(A) receptor complex reveals that it may act via the picrotoxin site // J. Pharmacology, and Exptl Therap. 1997. V. 282. No 2. P. 827.
42. Stackman R.W., Walsh T.J., Brucato F.H., Swartzwelder H.S. Medial septal benzodiazepine receptors modulate hippocampal evoked responses and long-term potentiation // Brain Res. 1996. V. 717. No 1-2. P. 12.
43. Stephens D.N., Turski L. Kindling to the benzodiazepine receptor inverse agonist, FG 7142: evidence for involvement of NMDA, but not non-NMDA, glutamatergic receptors // Neuropharmacology. 1993. V. 132. No 10. P. 1011.
44. Summers M.J., Crowe S.F., Ng K.T. Administration of glutamate following a reminder induces transient memory loss in day-old chicks // Cogn. Brain Res. 1995. V. 3. No 1. P. 1.
45. Summers M.J., Crowe S.F., Ng K.T. Administration of lanthanum cloride following a reminder induces a transient loss of memory retrieval in day-old chicks // Cogn. Brain Res. 1996. V. 4. No 2. P. 109.
46. Summers M.J., Crowe S.F., Ng K.T. Administration of DL-2-amino-5-phosphonovaleric acid (AP5) induces transient inhibition of reminder-activated memory retrieval in day-old chicks // Cogn. Brain Res. 1997. V. 5. No 4. P. 311.
47. Talalaenko A.N., Abramets I.A., Stakhovskii Yu.V. et al. The role of dopaminergic mechanisms on the brain in various models of anxious states // Neurosci. Behav. Physiol. 1994. V. 24. No 3. P. 284.
48. The WAG/Raj Rat Model of Absence Epilepsy: Ten Years of Research. (A Compilation of Papers) / Eds. Van Luijtelaar E.L.J.M., Coenen A. Nijmegen: Nijmegen Univ. Press, 1997. 433 p.
49. Thibonnier M. Signal transduction of V1-vascular vasopressin receptors // Regul. Peptides. 1992. V. 38. No 1. P. 1.
50. Tiihonen J., Kuikka J., Rasanen P., et al. Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis // Mol. Psychiatry. 1997. V. 2. No 6. P. 463.
51. Tokunaga M., Ida I., Higuchi T., Mikuni M. Alterations of benzodiazepine receptor binding potential in anxiety and somatoform disorders measured by 123I-iomazenil SPECT // Radiat. Med. 1997. V. 15. No 3. P. 163.
52. Tucci S., Fernandez R., Baptista T., Murzi E. et al. Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats. // Brain Res. Bull. 1994. V. 35. No 2. P. 125.
53. Turski L., Klockgether T., Turski W.A. et al. Blockade of excitatory neurotransmission in the globus pallidus induces rigidity and akinesia in the rat: implications for excitatory neurotransmission in pathogenesis of Parkinson's diseases // Brain Res. 1990. V. 512. No 1. P. 125.
54. Urbanska E., Ikonomidou C., Sieklucka M., Turski W.A. Aminooxyacetic acid produces excitotoxic lesions in the rat striatum // Synapse. 1991. V. 9. No 2. P. 129.
55. Vale C., Pomes A., Rodriguez-Farre E., Sunol C. Allosteric interactions between gamma-aminobutyric acid, benzodiazepine and picrotoxinin binding sites in primary cultures of cerebellar granule cells. Differential effects induced by gamma- and delta-hexachlorocyclohexane // Europ. J. Pharmacol. 1997. V. 319. No 2-3. P. 343.
56. Vignes M., Collingridge G.L. The synaptic activation of kainate receptors // Nature. 1997. V. 388. No 6638. P. 179.
57. Wilson M.A. GABA physiology: modulation by benzo-diazepines and hormones // Crit. Rev. Neurobiol. 1996. V. 10. No 1. P. 1.
58. Yoshida Y., Ono T., Kizu A., et al. Striatal N-methyl-D-aspartate receptors in haloperidol-induced catalepsy // Europ. J. Pharmacol. 1991. V. 203. No 2. P. 173.
59. Yoshida Y., Ono T., Kawano K., Miyagishi T. Distinct sites of dopaminergic and glutamatergic regulation of haloperidol-induced catalepsy within the rat caudateputamen // Brain Res. 1994. V. 639. No 1. P. 139.